Dr. Mark Thongmee, M.D., MRCP (UK), is a translational research physician trained in Translational Medicine and Early Phase Development from Imperial College London.
With over a decade of experience, he has contributed significantly to clinical trials in infectious diseases and oncology across Southeast Asia, including leading community-based trials for HIV and HCV. He has spearheaded numerous research trials and medical initiatives, notably as;